3403 Final overall survival (OS) analysis of the randomized phase 3 study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS)
EUROPEAN JOURNAL OF CANCER（2015）
Key words
advanced leiomyosarcoma,liposarcoma,trabectedin,dacarbazine,final overall survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined